|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn874145974 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
130215s2012 enka ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d YDXCP
|d IDEBK
|d OCLCF
|d OCLCO
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d D6H
|d OCLCO
|d YDX
|d COCUF
|d AGLDB
|d MOR
|d PIFPO
|d RTH
|d ZCU
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d STF
|d VNS
|d OCLCO
|d VTS
|d OCLCO
|d NRAMU
|d EZ9
|d VT2
|d ICG
|d OCLCO
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d TKN
|d OCLCO
|d K6U
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d M8D
|d OCLCO
|d UKAHL
|d UX1
|d OCLCQ
|d OCLCA
|d AJS
|d OCLCO
|d OCLCQ
|d QGK
|d OCLCO
|
066 |
|
|
|c (S
|
016 |
7 |
|
|a 101595489
|2 DNLM
|
019 |
|
|
|a 868069009
|a 869435495
|a 923424666
|a 961586707
|a 962696497
|a 966582820
|a 1047641697
|a 1055315291
|a 1065700574
|a 1081210793
|a 1228563315
|a 1259168277
|
020 |
|
|
|a 9781908986719
|q (e-book)
|
020 |
|
|
|a 1908986719
|q (e-book)
|
020 |
|
|
|z 9781903378786
|
020 |
|
|
|z 1903378788
|
020 |
|
|
|a 1908986697
|
020 |
|
|
|a 9781908986696
|
029 |
1 |
|
|a AU@
|b 000053336781
|
029 |
1 |
|
|a DEBBG
|b BV043785496
|
029 |
1 |
|
|a DEBBG
|b BV044056921
|
029 |
1 |
|
|a DEBSZ
|b 472814559
|
029 |
1 |
|
|a NZ1
|b 15499823
|
035 |
|
|
|a (OCoLC)874145974
|z (OCoLC)868069009
|z (OCoLC)869435495
|z (OCoLC)923424666
|z (OCoLC)961586707
|z (OCoLC)962696497
|z (OCoLC)966582820
|z (OCoLC)1047641697
|z (OCoLC)1055315291
|z (OCoLC)1065700574
|z (OCoLC)1081210793
|z (OCoLC)1228563315
|z (OCoLC)1259168277
|
050 |
|
4 |
|a RC660
|b .E94 2012eb
|
060 |
|
4 |
|a 2012 I-436
|
060 |
|
4 |
|a WK 815
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.4/62
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Evidence-based management of diabetes /
|c [edited by] Jiten Vora, John Buse.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a Harley :
|b Tfm Publishing,
|c 2012.
|
300 |
|
|
|a 1 online resource (522 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a COVER FRONT -- Contents -- Foreword -- Contributors -- Acknowledgements -- Using evidence-based medicine -- Chapter 1 Where does insulin resistance start; contribution to the development of diabetes? -- Chapter 2 Genetics studies in diabetes � how do they help? -- Chapter 3 Prevention of type 2 diabetes in high-risk individuals: achievable? -- Chapter 4 The glucocentric approach to diabetes care -- Chapter 5 Supplying the missing link in diabetes care: evidence-based structured education for people with type 2 diabetes
|
505 |
8 |
|
|a Chapter 6 The role of blood glucose monitoring in type 2 diabetes a plea for common sense? -- Chapter 7 The role of continuous glucose monitoring in the management of type 1 and type 2 diabetes -- Chapter 8 Treatment of diabetes through targeting weight loss -- Chapter 9 Weight loss therapies in diabetes � is there a future? -- Chapter 10 Goals of treatment in type 2 diabetes mellitus: β-cell preservation -- Chapter 11 Early insulin initiation in type 2 diabetes -- Chapter 12 Immune intervention in type 1 diabetes
|
505 |
8 |
|
|a Chapter 13 Pancreas and islet transplantation: an evidence-based analysisChapter 14 Hypoglycemia in type 2 diabetes: does it matter? -- Chapter 15 Mental illness and diabetes � intricate interplay -- Chapter 16 Diabetes treatments and cancer -- Chapter 17 Screening for diabetic retinopathy -- Chapter 18 Medical therapies for diabetic eye disease � how good are they? -- Chapter 19 Diabetic neuropathic pain � assessment and treatment -- Chapter 20 The diabetic foot: where are we?
|
505 |
8 |
|
|a Chapter 21 Non-alcoholic fatty liver disease (NAFLD) in diabetes: distraction or impending disaster?Chapter 22 Management of kidney risk in diabetes -- Chapter 23 Use of dual RAAS blockade in diabetic nephropathy -- Chapter 24 Glucose control and macrovascular disease/morbidity -- Chapter 25 Hyperglycemia in acute coronary syndromes -- Chapter 26 Screening for coronary artery disease in patients with type 2 diabetes -- Index -- COVER BACK
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Diabetes
|x Treatment.
|
650 |
|
0 |
|a Evidence-based medicine.
|
650 |
|
2 |
|a Diabetes Mellitus
|x therapy
|
650 |
|
2 |
|a Evidence-Based Medicine
|
650 |
|
2 |
|a Evidence-Based Practice
|
650 |
|
6 |
|a Médecine factuelle.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Diabetes
|x Treatment
|2 fast
|
650 |
|
7 |
|a Evidence-based medicine
|2 fast
|
700 |
1 |
|
|a Vora, Jiten.
|
700 |
1 |
|
|a Buse, John B.
|
776 |
0 |
8 |
|i Print version:
|t Evidence-based management of diabetes.
|d Harley : tfm Publishing, 2012
|h xiv, 506 pages : illustrations (some color) ; 25 cm.
|z 9781903378786
|w (DLC) 2012538075
|w (OCoLC)816100673
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=685415
|z Texto completo
|
880 |
0 |
|
|6 505-00/(S
|a Where does insulin resistance start: contribution to the development of diabetes? -- Genetics studies in diabetes: how do they help? -- Prevention of type 2 diabetes in high-risk individuals: achievable? -- Glucocentric approach to diabetes care -- Supplying the missing link in diabetes care: evidence-based structured education for people with type 2 diabetes -- Role of blood glucose monitoring in type 2 diabetes: a plea for common sense? -- Role of continuous glucose monitoring in the management of type 1 and type 2 diabetes -- Treatment of diabetes through targeting weight loss -- Weight loss therapie sin diabetes: is there a future? -- Goals of treatment in type 2 diabetes mellitus: β-cell preservation -- Early insulin initiation in type 2 diabetes -- Immune intervention in type 1 diabetes -- Pancreas and islet transplantation: an evidence-based analysis -- Hypoglycemia in type 2 diabetes: does it matter? -- Mental illness and diabetes: intricate interplay -- Diabetes treatmens and cancer -- Screening for diabetic retinopathy -- Medical therapies for diabetic eye disease: how good are they? -- Diabetic neuropathic pain: assessment and treatment -- Diabetic foot: where are we? -- Non-alcoholic fatty liver disease (NAFLD) in diabetes: distraction or impending disaster? -- Management of kidney risk in diabetes -- Use of dual RAAS blockade in diabetic nephropathy -- Glucose control and macrovascular disease/morbidity -- Hypereglycemia in acute coronary syndromes -- Screening for coronary artery disease in patients with type 2 diabetes.
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26971120
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH26183792
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3410354
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10827985
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 685415
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis27569363
|
938 |
|
|
|a Rittenhouse
|b RITT
|n 1903378788
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11574744
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 13305709
|
994 |
|
|
|a 92
|b IZTAP
|